Gary Crocker Net Worth & Insider Trades

Gary Crocker - Director, Merrimack Pharmaceuticals Inc

As of June 15, 2018

What is Gary Crocker's Net Worth?

The current estimated net worth of Merrimack Pharmaceuticals Inc's Director, Gary Crocker, is estimated to be about $2.13M . Gary Crocker owns about 2,858,961 units of Merrimack Pharmaceuticals Inc common stock. In the last 6 years at Merrimack Pharmaceuticals Inc, Gary Crocker has sold an estimated value of $0 worth.

What is Gary Crocker's Past Insider Trading?

Gary Crocker's largest purchase order was 2,430,031 units , worth over $979.99K on April 5, 2012. In total, Gary Crocker has made about 20 transactions over 6 years of their time at Merrimack Pharmaceuticals Inc. Gary Crocker usually trades in May, with the busiest year in 2014. The most recent transaction was a purchase order of 14,390 units , worth over $121.88K on November 14, 2014.

Gary L Crocker

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What was Gary Crocker's Salary in 2019?

As Director of Merrimack Pharmaceuticals Inc, Gary Crocker has a total base salary of $76,000 . Gary Crocker received compensation valued at about $95,258 in 2019 after becoming Director. The vast majority of their compensation came in the form of a bonus of $ , option awards of $19,258 , other earnings, plans or compensations of $ , and other compensation of $ .

What is Gary Crocker's' Mailing Address?

  • Mailing address is Merrimack Pharmaceuticals, Inc. One Kendall Square, Suite B7201 Cambridge MA 02139 MA

Merrimack Pharmaceuticals Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Gary L. Crocker 2019 $76,000 $ $19,258 $ $ $95,258
Richard Peters 2019 $383,676 $294,891 $ $ $935,369 $1,613,936
Jean M. Franchi 2019 $214,087 $77,544 $ $ $524,461 $816,092
Jeffrey A. Munsie 2019 $209,658 $72,015 $ $ $478,659 $760,332
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1274792/000119312521126831/d97305ddef14a.htm

What are Merrimack Pharmaceuticals Inc's Past Insider Trades?

Merrimack Pharmaceuticals Inc's most recent insider trade came on March 22, 2023 by Eric Andersen, Western Standard Llc, Western Standard Partners Lp and Western Standard Partners QP Lp who bought 160,590 units worth $1.85M . In the last 11 years, insiders at Merrimack Pharmaceuticals Inc have sold an estimated value of $15.57M and bought an estimated value of $27.66M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Gary L Crocker, See Remarks,  Michael Porter, Director,  and Edward Stewart, Head Commercial .

MERRIMACK PHARMACEUTICALS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...